{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:08:03Z","timestamp":1795039683136,"version":"4.10.2"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901286"],"award-info":[{"award-number":["81901286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974199"],"award-info":[{"award-number":["81974199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271458"],"award-info":[{"award-number":["82271458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28553","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:52:31Z","timestamp":1711515151000},"page":"e28553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum cytokines profile changes in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Chun-Zuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Shan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9481-1418","authenticated-orcid":false,"given":"Chong-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Yu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-015X","authenticated-orcid":false,"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e28553_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e28553_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ana.26045","article-title":"Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis","volume":"89","author":"Hannaford","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e28553_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e28553_bib5","first-page":"7","article-title":"Amyotrophic lateral sclerosis and environmental factors","volume":"31","author":"Bozzoni","year":"2016","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fneur.2019.00400","article-title":"A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS","volume":"10","author":"Vijayakumar","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib7","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1007\/s12035-020-02053-7","article-title":"Causal association of leukocytes count and amyotrophic lateral sclerosis: a mendelian randomization study","volume":"57","author":"Li","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.clinthera.2020.01.010","article-title":"Amyotrophic lateral sclerosis, neuroinflammation, and cromolyn","volume":"42","author":"Theoharides","year":"2020","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e28553_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib10","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI90607","article-title":"Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia","volume":"127","author":"Lall","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e28553_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74065","article-title":"Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis","volume":"11","author":"Cui","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2024.e28553_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","article-title":"Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model","volume":"75","author":"Sheean","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000465","article-title":"Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study","volume":"5","author":"Thonhoff","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.heliyon.2024.e28553_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.890958","article-title":"Neuroimmune crosstalk between the peripheral and the central immune system in amyotrophic lateral sclerosis","volume":"14","author":"Yu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2024.e28553_bib15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.heliyon.2024.e28553_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2007.10.028","article-title":"TNF and sTNFR1\/2 plasma levels in ALS patients","volume":"194","author":"Cereda","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-11-94","article-title":"Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis","volume":"11","author":"Italiani","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e28553_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib19","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS","volume":"6","author":"Kasai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.heliyon.2024.e28553_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e28553_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jcmm.17100","article-title":"Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"26","author":"Shi","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e28553_bib22","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00415-018-9043-0","article-title":"Significance of CSF NfL and tau in ALS","volume":"265","author":"Schreiber","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib23","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2024.e28553_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e28553_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.579094","article-title":"Correlational analysis of ALS progression and serum NfL measured by simoa assay in Chinese patients","volume":"11","author":"Sugimoto","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib26","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","article-title":"Sample size estimation in diagnostic test studies of biomedical informatics","volume":"48","author":"Hajian-Tilaki","year":"2014","journal-title":"J. Biomed. Inf."},{"key":"10.1016\/j.heliyon.2024.e28553_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e28553_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e28553_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in Parkinson disease","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e28553_bib32","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2174\/1567205017666201130092427","article-title":"The association between TNF-alpha, IL-1 alpha and IL-10 with alzheimer's disease","volume":"17","author":"Culjak","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.heliyon.2024.e28553_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158042","article-title":"Interleukin-17 and Th17 lymphocytes directly impair motoneuron survival of wildtype and FUS-ALS mutant human iPSCs","volume":"22","author":"Jin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e28553_bib34","article-title":"Eomesodermin expression in CD4+T\u2010cells associated with disease progression in amyotrophic lateral sclerosis","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.heliyon.2024.e28553_bib35","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e28553_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e28553_bib37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nn1876","article-title":"Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons","volume":"10","author":"Nagai","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e28553_bib38","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"Chiu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2024.e28553_bib39","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e28553_bib40","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e28553_bib41","first-page":"53","volume":"vol. 12","author":"Nakanishi","year":"2001"},{"key":"10.1016\/j.heliyon.2024.e28553_bib42","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1007\/s00018-013-1425-y","article-title":"IL-18 in inflammatory and autoimmune disease","volume":"70","author":"Sedimbi","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e28553_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","article-title":"NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model","volume":"41","author":"Gugliandolo","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e28553_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41593-022-01040-6","article-title":"Whole-genome sequencing reveals that variants in the interleukin 18 receptor accessory protein 3'UTR protect against ALS","volume":"25","author":"Eitan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e28553_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-022-02466-9","article-title":"Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex","volume":"144","author":"Van Schoor","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib46","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","article-title":"IL-21 mediates suppressive effects via its induction of IL-10","volume":"182","author":"Spolski","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib47","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.4049\/jimmunol.1400775","article-title":"IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1\/17 effector cells","volume":"193","author":"Kastirr","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1109797109","article-title":"Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e28553_bib49","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3233\/JAD-191120","article-title":"Soluble TREM2 and inflammatory proteins in Alzheimer's disease cerebrospinal fluid","volume":"73","author":"Rauchmann","year":"2020","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2024.e28553_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jim.2015.06.009","article-title":"The effects of age and gender on plasma levels of 63 cytokines","volume":"425","author":"Larsson","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.heliyon.2024.e28553_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/819724","article-title":"Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer","volume":"2011","author":"Pellegrini","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib52","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.heliyon.2024.e28553_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103732","article-title":"Predictors of survival in patients with amyotrophic lateral sclerosis: a large meta-analysis","volume":"74","author":"Su","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e28553_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024045845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024045845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:06:38Z","timestamp":1784207198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024045845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024045845"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28553","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cytokines profile changes in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28553"}}